locally manufactured adoptive cellular therapy (ACT) product Clinical Trials

2 actively recruiting trials across 1 location

No change since May 2026

Also known as: ACT, Fast TIL

Pipeline

Phase 1: 2

Top Sponsors

David Bartlett, MD1
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)1

Indications

Metastasis to Pleura2
Pleural Effusion, Malignant2
Malignant Pleural Effusion2
Malignant Mesothelioma2
Lung Cancer2

Pittsburgh, Pennsylvania2 trials

Fast TILs to Treat Metastatic Cancer Patients With Pleural Disease

AHN West Penn Hospital

Phase 1

Fast TILs to Treat Metastatic Pleural Effusions From Epithelial or Mesothelial Primary Tumors

AHN West Penn Hospital

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.